ADMA Biologics Ownership | Who Owns ADMA Biologics?


OverviewForecastRevenueFinancialsChartTranscripts

ADMA Biologics Ownership Summary


ADMA Biologics is owned by 76.13% institutional investors, 1.87% insiders, and 22.01% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.25% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.08% of its assets in ADMA Biologics shares.

ADMA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockADMA Biologics76.13%1.87%22.01%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de38.36M16.25%$321.04M
Vanguard group20.85M8.74%$380.39M
Blackrock18.64M8.15%$208.45M
State street17.12M7.25%$143.26M
Capital research global investors11.19M4.70%$100.83M
First trust advisors lp7.80M3.30%$65.27M
Geode capital management5.82M2.44%$52.48M
Citadel advisors5.81M2.44%$52.35M
American century companies4.79M2.01%$43.15M
Caligan partners lp4.76M2.00%$42.86M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
B group3.21M21.43%$28.90M
Caligan partners lp4.76M2.85%$42.86M
Stonepine capital management740.00K2.67%$6.67M
Ophir asset management pty1.26M2.27%$18.40M
Oberweis asset management inc/2.71M1.52%$39.76M
Ranger investment management2.28M1.49%$20.58M
First light asset management1.07M1.48%$15.67M
Mesirow institutional investment management782.45K1.03%$13.42M
Marathon capital management532.35K0.90%$4.46M
Clarivest asset management575.25K0.66%$6.43M

Top Buyers

HolderShares% AssetsChange
First trust advisors lp7.80M0.04%7.44M
Capital research global investors11.19M0.02%4.55M
Citadel advisors5.81M0.01%4.29M
State street17.12M0.00%3.03M
Point72 asset management3.29M0.04%2.89M

Top Sellers

HolderShares% AssetsChange
Sachem head capital management lp---11.38M
Invesco4.12M0.01%-7.67M
Westfield capital management co lp---6.99M
Janus henderson group98.26K0.00%-3.84M
Thrivent financial for lutherans158.86K0.00%-3.63M

New Positions

HolderShares% AssetsChangeValue
Rubric capital management lp1.81M0.17%1.81M$16.30M
Vanguard fiduciary trust1.64M0.00%1.64M$14.75M
Clearline capital lp556.05K0.26%556.05K$5.01M
Ruffer llp422.96K0.13%422.96K$3.54M
Ashford capital management361.50K0.40%361.50K$3.26M

Sold Out

HolderChange
Tfc financial management-1.00
Dunhill financial-1.00
Curio wealth-3.00
Mendota financial group-4.00
Global wealth strategies & associates-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026318-14.29%181,408,566-17.67%760.89%166-17.82%106-10.92%
Dec 31, 2025122-68.06%37,183,315-83.04%150.19%65-60.37%34-78.48%
Sep 30, 2025154-58.93%47,734,498-76.76%190.27%60-74.36%68-33.98%
Jun 30, 20253764.16%204,872,1710.17%841.15%23018.56%107-6.96%
Mar 31, 20253578.51%204,309,7520.18%851.14%192-4.00%1139.71%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF14.12M6.08%9.36K
First Trust NYSE Arca Biotech ETF10.02M4.31%-91.48K
American Funds SMALLCAP World A8.52M3.67%-1.76M
State Street® SPDR® S&P® Biotech ETF7.65M3.29%17.57K
Vanguard Morn Total Stk Mkt Idx Investor7.03M3.02%-158.62K
Vanguard Total Stock Mkt Idx Inv7.03M3.02%-158.62K
Vanguard US Total Market Shares ETF7.15M3.01%281.42K
iShares Russell 2000 ETF5.86M2.52%-104.06K
American Century Small Cap Growth Inv3.36M1.45%200.08K
American Century U.S. Small Cap Growth3.36M1.45%200.08K

Recent Insider Transactions


DateNameRoleActivityValue
May 27, 2026Grossman Jerrold B-Buy$50.62K
May 12, 2026Grossman Jerrold B-Buy$100.13K
May 11, 2026Grossman Jerrold B-Buy$100.13K
Mar 16, 2026Grossman Adam S President and CEOSell$227.40K
Mar 16, 2026Grossman Adam S President and CEOSell$90.96K

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q23-
2026 Q125
2025 Q4-6
2025 Q3-6

ADMA Ownership FAQ


Who Owns ADMA Biologics?

ADMA Biologics shareholders are primarily institutional investors at 76.13%, followed by 1.87% insiders and 22.00% retail investors. The average institutional ownership in ADMA Biologics's industry, Biotech Stocks , is 35.43%, which ADMA Biologics exceeds.

Who owns the most shares of ADMA Biologics?

ADMA Biologics’s largest shareholders are Blackrock funding, inc. /de (38.36M shares, 16.25%), Vanguard group (20.85M shares, 8.74%), and Blackrock (18.64M shares, 8.15%). Together, they hold 33.13% of ADMA Biologics’s total shares outstanding.

Does Blackrock own ADMA Biologics?

Yes, BlackRock owns 8.15% of ADMA Biologics, totaling 18.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 208.45M$. In the last quarter, BlackRock increased its holdings by 445.43K shares, a 2.45% change.

Who is ADMA Biologics’s biggest shareholder by percentage of total assets invested?

B group is ADMA Biologics’s biggest shareholder by percentage of total assets invested, with 21.43% of its assets in 3.21M ADMA Biologics shares, valued at 28.9M$.

Who is the top mutual fund holder of ADMA Biologics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ADMA Biologics shares, with 6.08% of its total shares outstanding invested in 14.12M ADMA Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools